Quercus Immuno Consulting
- Therapies are increasingly evaluated with respect to health outcomes.
- The classical business model of the pharmaceutical industry needs to adopt to the new healthcare environment.
- The spotlight shifts towards the “3P –Stakeholders”: Patients, Payers, Politics.
- We help you to manage the necessary adjustments in clinical R&D and beyond.